Literature DB >> 24254396

Serum selenium concentrations in ovarian cancer patients using a simplified fluorimetric procedure.

N P Das1, C W Ma, Y M Salmon.   

Abstract

The serum selenium (Se) concentrations were determined to be 105.6±15.6 μg/L ([Formula: see text]) and 116.7±18.4 μg/L ([Formula: see text]) for the ovarian cancer patients and the control subjects in Singapore, respectively (p<0.0065). When we separated the patients into three age groups, namely <30, 30-50, and >50 yr, the ovarian cancer patients showed significantly lower mean serum Se levels than the control subjects for the 30-50-yr age group only. However, when the analysis of variance was used to evaluate the data, the values indicated that the age of the subject did not significantly affect the serum Se level. Our findings suggest that there is an inverse relationship between serum Se concentration and the incidence of human ovarian cancer.A modified simple fluorimetric method for the determination of serum Se concentration is described. The procedure, with a sensitivity limit of 5 μg/L and percentage recoveries of 96.2-100.7%, requires only 0.2 mL of serum sample.

Entities:  

Year:  1986        PMID: 24254396     DOI: 10.1007/BF02795620

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  22 in total

1.  Selenium: biochemical role as a component of glutathione peroxidase.

Authors:  J T Rotruck; A L Pope; H E Ganther; A B Swanson; D G Hafeman; W G Hoekstra
Journal:  Science       Date:  1973-02-09       Impact factor: 47.728

2.  Selenium in human nutrition: dietary intakes and effects of supplementation.

Authors:  G N Schrauzer; D A White
Journal:  Bioinorg Chem       Date:  1978-04

3.  Selenium concentrations in plasma of patients with arteriographically defined coronary atherosclerosis.

Authors:  J A Moore; R Noiva; I C Wells
Journal:  Clin Chem       Date:  1984-07       Impact factor: 8.327

4.  Selenium and the genesis of murine mammary tumors.

Authors:  C W Welsch; M Goodrich-Smith; C K Brown; H D Greene; E J Hamel
Journal:  Carcinogenesis       Date:  1981       Impact factor: 4.944

5.  Serum selenium levels in malignant lymphoproliferative diseases.

Authors:  P Calautti; G Moschini; B M Stievano; L Tomio; F Calzavara; G Perona
Journal:  Scand J Haematol       Date:  1980-01

6.  Selenium in the blood of Japanese and American women with and without breast cancer and fibrocystic disease.

Authors:  G N Schrauzer; T Molenaar; S Mead; K Kuehn; H Yamamoto; E Araki
Journal:  Jpn J Cancer Res       Date:  1985-05

7.  Selenium and cancer: effects of selenium and of the diet on the genesis of spontaneous mammary tumors in virgin inbred female C3H/St mice.

Authors:  G N Schrauzer; D A White; C J Schneider
Journal:  Bioinorg Chem       Date:  1978

8.  Congestive cardiomyopathy and the selenium content of serum.

Authors:  O Oster; W Prellwitz; W Kasper; T Meinertz
Journal:  Clin Chim Acta       Date:  1983-02-28       Impact factor: 3.786

9.  Inhibition of the genesis of spontaneous mammary tumors in C3H mice: effects of selenium and of selenium-antagonistic elements and their possible role in human breast cancer.

Authors:  G N Schrauzer; D A White; C J Schneider
Journal:  Bioinorg Chem       Date:  1976

10.  Risk of cancer in relation to serum concentrations of selenium and vitamins A and E: matched case-control analysis of prospective data.

Authors:  J T Salonen; R Salonen; R Lappeteläinen; P H Mäenpää; G Alfthan; P Puska
Journal:  Br Med J (Clin Res Ed)       Date:  1985-02-09
View more
  2 in total

Review 1.  Determination of selenium in blood components by X-ray emission spectrometry. Procedures, concentration levels, and health implications.

Authors:  H Robberecht; H Deelstra; R Van Grieken
Journal:  Biol Trace Elem Res       Date:  1990-06       Impact factor: 3.738

2.  Total and individual antioxidant intake and risk of epithelial ovarian cancer.

Authors:  Dina Gifkins; Sara H Olson; Lisa Paddock; Melony King; Kitaw Demissie; Shou-En Lu; Ah-Ng Tony Kong; Lorna Rodriguez-Rodriguez; Elisa V Bandera
Journal:  BMC Cancer       Date:  2012-06-01       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.